FCR Plus Sargramostim (GM-CSF) as Frontline Therapy for Symptomatic Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLL
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1, Dose-Escalation, Pharmacodynamic Study of IV CNF1010 in ZAP-70 Positive CLL
- Status
- TERMINATED
- Phase
- PHASE1
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)
- Status
- COMPLETED
- Phase
- PHASE2
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
SPC2996 in Chronic Lymphocytic Leukaemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Study of Immune Response Modifier in the Treatment of Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2